BiotechTube

Maraviroc + Vardenafil + Maraviroc + Placebo

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

AIDS

Conditions

AIDS

Trial Timeline

Apr 1, 2008 → May 1, 2008

NCT ID
NCT00853840

About Maraviroc + Vardenafil + Maraviroc + Placebo

Maraviroc + Vardenafil + Maraviroc + Placebo is a approved stage product being developed by Pfizer for AIDS. The current trial status is completed. This product is registered under clinical trial identifier NCT00853840. Target conditions include AIDS.

What happened to similar drugs?

3 of 10 similar drugs in AIDS were approved

Approved (3) Terminated (1) Active (7)
✅TruvadaGilead SciencesApproved
✅bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) + Standard initiation of antiretroviral therapy (ART)Gilead SciencesApproved
✅Emtricitabine and TenofovirGilead SciencesApproved
🔄EsomeprazoleAstraZenecaPhase 3
🔄EsomeprazoleAstraZenecaPhase 3
🔄Recombinant Human Papillomavirus Nonavalent VaccineMerckPhase 3
🔄Biktarvy + SymtuzaGilead SciencesPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00853840ApprovedCompleted

Competing Products

20 competing products in AIDS

See all competitors
ProductCompanyStageHype Score
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
SelumetinibAstraZenecaPhase 1/2
24
MetforminMerckPhase 2/3
34
Trivalent MRKAd5 HIV-1 gag/pol/nef (1.5x10^10 ad-vg/dose) + Comparator: placeboMerckPhase 2
27
Recombinant Human Papillomavirus Nonavalent VaccineMerckPhase 3
40
rituximab + CHOPRochePhase 2
27
R-EPOCH and cARTRochePhase 2
35
Elvitegravir, Cobicistat, TAF, FTC + Efavirenz, TDF, and 3TCGilead SciencesPre-clinical
18
Switch to E/C/FTC/TAF dailyGilead SciencesPhase 1/2
32
Biktarvy + SymtuzaGilead SciencesPhase 3
40
TruvadaGilead SciencesApproved
43
ATV + DRV + Cobicistat + BR + F/TAF + LPV/r + Third Unboosted Drug + Cobicistat TOS + F/TAF TOSGilead SciencesPhase 2/3
42
bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) + Standard initiation of antiretroviral therapy (ART)Gilead SciencesApproved
35
ChAdOx1.HTI + MVA.HTI + GS-9620 + Placebo + Placebo Oral TabletGilead SciencesPhase 2
35
E/C/F/TAF + E/C/F/TAF (Low Dose)Gilead SciencesPhase 2/3
38
EVG + Background regimenGilead SciencesPhase 2/3
30
Emtricitabine and TenofovirGilead SciencesApproved
39
TDF/FTC 300mg/200mg fixed-dose combination tablets + TAF/FTC 25mg/200mg fixed-dose combination tabletsGilead SciencesPhase 3
47
MaravirocPfizerPhase 1
29